| Product definition and U-40 compatibility | Specify needle type, dimensions, intended syringe connection, and intended use. Label U-40 compatibility only where the complete intended delivery system has been assessed; a needle does not determine insulin concentration or dose scale. | ISO 8537 applies to insulin syringes; verify the current edition and applicable national regulations. |
| Quality management and traceability | Maintain controlled procedures, trained personnel, supplier controls, batch records, nonconformance handling, corrective actions, and traceability of materials and finished lots. | ISO 13485: medical-device quality management systems. |
| Needle tubing and material checks | Verify tubing material and specified dimensions; inspect for relevant defects and confirm supplier documentation. Record inspection methods, equipment calibration, and lot acceptance results. | ISO 9626 specifies requirements and test methods for stainless-steel needle tubing. |
| Finished needle dimensions and construction | Measure and inspect length, outside diameter, hub or connection features, and other product-specific characteristics against the approved drawing and specification. | ISO 7864 covers sterile single-use hypodermic needles; requirements depend on the needle design and intended use. |
| Tip sharpness and physical integrity | Use validated inspection and test methods for the needle point, finish, and relevant mechanical characteristics. Set acceptance criteria in the product specification and retain batch test records. | ISO 7864 includes requirements and test methods for sterile single-use hypodermic needles. |
| Cleanliness and particulate control | Control manufacturing-area conditions and cleaning processes; inspect or test finished products using validated methods appropriate to the device and applicable requirements. | Establish controls through the device risk-management and quality-system processes; applicable regulatory requirements vary by market. |
| Biological safety | Assess materials and manufacturing residues according to the nature and duration of patient contact. Use a documented biological evaluation; testing is selected based on risk, not assumed to be identical for every product. | ISO 10993-1 provides a framework for biological evaluation of medical devices within a risk-management process. |
| Sterilization validation and routine control | Validate the selected sterilization process, define routine process parameters, monitor each cycle or production run as applicable, and maintain records. The method must be compatible with the device and packaging. | ISO 11135 addresses ethylene oxide sterilization; ISO 11137 addresses radiation sterilization. Apply the standard relevant to the validated method. |
| Sterile barrier and packaging | Validate packaging forming, sealing, and assembly processes. Verify package integrity and that the sterile barrier can be maintained through the claimed shelf life and distribution conditions. | ISO 11607 addresses packaging for terminally sterilized medical devices. |
| Risk management and labeling review | Document hazards and risk controls across the product life cycle. Review instructions and labels for intended use, single-use status where applicable, sterility information, and clear distinction between needle compatibility and U-40 syringe calibration. | ISO 14971 provides a framework for medical-device risk management; labeling obligations depend on the target market. |
| Lot release and ongoing monitoring | Release lots only after review of specified inspection, test, sterilization, and packaging records. Trend complaints and nonconformities, investigate adverse signals, and maintain post-market processes as required. | Apply the quality-management system and the regulatory requirements of each intended market. |